市场调查报告书
商品编码
1471172
白血球分离术市场:按类型、应用和最终用户划分 - 全球预测,2024-2030 年Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年Leucafferesis市场规模为5,621万美元,2024年达6,162万美元,预计2030年将达到1,0758万美元,复合年增长率为9.71%。
白血球去除术包括与从患者或捐赠者的血液中选择性去除白血球(白血球)相关的产品、设备、程序和服务。它包括不同类型的白血球分离术,例如自体血球移植和同种异体血球移植,并应用于癌症治疗、造血干细胞移植(HSCT)、慢性发炎疾病管理和免疫系统调节等各个治疗领域。由于对老龄化相关疾病的易感性增加,不断扩大的老年人口增加了对白血球去除术治疗的需求。然而,与白血球分离术所需的设备和消耗品相关的高成本对患者和医疗保健提供者构成了重大障碍。然而,将白血球分离衍生的细胞应用于再生医学和其他应用的临床试验正在进行中,为白血球分离市场创造了潜力。
主要市场统计 | |
---|---|
基准年[2023] | 5621万美元 |
预测年份 [2024] | 6162万美元 |
预测年份 [2030] | 10758万美元 |
复合年增长率(%) | 9.71% |
类型:更多地使用白血球分离装置来有效分离白血球
白血球分离设备是用于在各种医疗应用中从捐赠者或患者血液中分离白血球的专用设备,包括癌症研究、细胞疗法开发和临床输血。这些设备旨在确保高品质的细胞分离,同时最大限度地减少对收穫细胞的损害。离心白血球分离装置利用离心原理,根据白血球的密度来分离白血球。膜分离器使用多孔膜根据白血球和其他血液成分的大小分离它们。白血球分离术抛弃式是白血球分离术过程中使用的一次性无菌组件,用于在细胞收集和分离过程中保持无菌。包括单采套件、管组、过滤器、收集袋等。
应用:白血球去除术在治疗上的应用越来越多,以改善患者的治疗效果。
对于研究应用,白血球分离术透过分离白血球和进行高品质的样本分析,促进血癌、干细胞研究和免疫学研究。白血球分离术在研究应用中的使用越来越多,主要是因为它能够提供纯净和浓缩的样品,从而改善实验结果并产生准确的结果。在治疗方面,白血球分离术在各种医疗程序中发挥重要作用,包括造血干细胞移植 (HSCT)、CAR-T 细胞治疗、移植医学和自体免疫疾病管理。治疗应用可以提供临床益处,例如透过去除多余的白血球或促进标靶细胞治疗来降低疾病严重程度并改善患者预后。
最终用户:血液成分提供者和血液中心扩大白血球分离装置的使用
学术和研究机构致力于研究白血球在各种疾病中的作用并开发新的治疗策略。血液成分供应商和血液中心需要有效的白血球分离设备来分离输血和治疗目的所需的特定血液成分。合约研究委外研发机构(CRO) 需要白血球分离术产品和服务来代表製药和生物技术公司支援临床试验和药物开发流程。医院和输血中心需要白血球分离装置来治疗性地减少白血病和其他血液疾病患者的白血球。製药和生物技术公司正在投资先进的白血球分离设备,以支援与免疫系统相关的各种疾病和病症的新药的研发。
区域洞察
由于强大的医疗基础设施、白血病盛行率的增加以及先进技术的采用,美洲白血球去除术市场正在发展。在欧盟 (EU),血液疾病的增加增加了对白血球分离产品的需求。在欧洲、中东和非洲,人们对白血病治疗方案认识的提高和医疗基础设施的改善正在推动对白血球去除术产品的需求。在亚太地区,由于医疗保健成本不断上升、人们对血液疾病的认识不断提高以及医疗技术的进步,白血球清除术市场正在显着增长。白血球分离装置的进步预计也将改善治疗效果并加速全球最终用途领域的部署。
FPNV定位矩阵
FPNV 定位矩阵对于评估白血球去除术市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对 Leucafferesis 市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、碎片化主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动和突破性产品开发的智力见解。
1.Leucafferesis市场的市场规模和预测是多少?
2.在Leucafferesis市场的预测期内,我们应该考虑投资哪些产品和应用?
3.白血球分离术市场的技术趋势和法规结构是什么?
4.Leucafferesis市场主要供应商的市场占有率是多少?
5. 进入Leucaferesis市场的适当形式和策略手段是什么?
[190 Pages Report] The Leukapheresis Market size was estimated at USD 56.21 million in 2023 and expected to reach USD 61.62 million in 2024, at a CAGR 9.71% to reach USD 107.58 million by 2030.
The leukapheresis includes the products, devices, procedures, and services related to selectively removing white blood cells (leukocytes) from a patient's or donor's blood. It encompasses different types of leukapheresis procedures, such as autologous leukapheresis and allogeneic leukapheresis, which are applied across various therapeutic areas, including cancer treatment, hematopoietic stem cell transplantation (HSCT), chronic inflammatory diseases management, and immune system regulation. The expanding geriatric population increases the demand for leukapheresis treatments due to their increased susceptibility to age-related diseases. However, the high costs associated with devices and consumables necessary for leukapheresis pose significant barriers for patients and healthcare providers. Nevertheless, ongoing clinical trials exploring novel applications of leukapheresis-derived cells in areas including regenerative medicine present potential opportunities for the leukapheresis market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 56.21 million |
Estimated Year [2024] | USD 61.62 million |
Forecast Year [2030] | USD 107.58 million |
CAGR (%) | 9.71% |
Type: Increasing use of leukapheresis devices for efficient separation of white blood cells
Leukapheresis devices are specialized equipment used to separate white blood cells from the blood of donors or patients for various medical applications such as cancer research, cell therapy development, or clinical transfusions. These devices are designed to ensure high-quality cell separation with minimal damage to the collected cells. The centrifugal leukapheresis devices use the principles of centrifugation to separate white blood cells based on their density. Membrane separators use porous membranes to separate leukocytes from other blood components based on their size. Leukapheresis disposables are single-use, sterile components used in the leukapheresis procedure to maintain aseptic conditions during cell collection and separation. These include apheresis kits, tubing sets, filters, and collection bags.
Application: Rising application of leukapheresis in therapeutics for improved patient outcome
In research applications, leukapheresis facilitates studying blood cancer types, stem cell research, and immunology by isolating white blood cells for high-quality sample analysis. The increasing use of leukapheresis in research applications arises primarily due to its ability to provide pure and concentrated samples that can improve experimental outcomes and facilitate accurate results. Therapeutically, leukapheresis has significant use in various medical procedures, including hematopoietic stem cell transplantation (HSCT), CAR-T cell therapy, transplantation medicine, and autoimmune disease management. Therapeutic applications provide clinical benefits such as reduced disease severity and improved patient outcomes by removing excess WBCs or facilitating targeted cellular therapies.
End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers
Academic and research Institutes focus on investigating the role of leukocytes in various diseases and developing new therapeutic strategies. Blood component providers and blood centers require effective leukapheresis devices to separate specific blood components needed for transfusions or therapeutic purposes. Contract Research Organizations (CROs) require leukapheresis products and services to support clinical trials and drug development processes on behalf of pharmaceutical and biotechnology companies. Hospitals and transfusion centers need leukapheresis devices to treat patients with leukemia or other hematological disorders through therapeutic leukocyte reduction. Pharmaceutical and biotechnology companies invest in advanced leukapheresis devices to support their research and development of new drugs targeting various diseases or conditions related to the immune system.
Regional Insights
The leukapheresis market is evolving in the Americas with robust healthcare infrastructure, increasing prevalence of leukemia, and adoption of advanced technologies. The European Union (EU) has shown a growing demand for leukapheresis products due to rising incidences of blood disorders. In the EMEA region, increased awareness about leukemia treatment options and improved healthcare infrastructure drive demand for leukapheresis products. The Asia Pacific region represents significant growth in the leukapheresis market due to increased healthcare expenditure, growing awareness of blood disorders, and advancements in healthcare technology. Besides, advancements in leukapheresis devices are anticipated to improve treatment outcomes and encourage their deployment across end-use sectors globally.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Leukapheresis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Leukapheresis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Leukapheresis Market, highlighting leading vendors and their innovative profiles. These include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Leukapheresis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Leukapheresis Market?
3. What are the technology trends and regulatory frameworks in the Leukapheresis Market?
4. What is the market share of the leading vendors in the Leukapheresis Market?
5. Which modes and strategic moves are suitable for entering the Leukapheresis Market?